Literature DB >> 26021808

TRPV1 sensitization mediates postinflammatory visceral pain following acute colitis.

Tamia K Lapointe1, Lilian Basso2, Mircea C Iftinca1, Robyn Flynn1, Kevin Chapman1, Gilles Dietrich2, Nathalie Vergnolle3, Christophe Altier4.   

Abstract

Quiescent phases of inflammatory bowel disease (IBD) are often accompanied by chronic abdominal pain. Although the transient receptor potential vanilloid 1 (TRPV1) ion channel has been postulated as an important mediator of visceral hypersensitivity, its functional role in postinflammatory pain remains elusive. This study aimed at establishing the role of TRPV1 in the peripheral sensitization underlying chronic visceral pain in the context of colitis. Wild-type and TRPV1-deficient mice were separated into three groups (control, acute colitis, and recovery), and experimental colitis was induced by oral administration of dextran sulfate sodium (DSS). Recovery mice showed increased chemically and mechanically evoked visceral hypersensitivity 5 wk post-DSS discontinuation, at which point inflammation had completely resolved. Significant changes in nonevoked pain-related behaviors could also be observed in these animals, indicative of persistent discomfort. These behavioral changes correlated with elevated colonic levels of substance P (SP) and TRPV1 in recovery mice, thus leading to the hypothesis that SP could sensitize TRPV1 function. In vitro experiments revealed that prolonged exposure to SP could indeed sensitize capsaicin-evoked currents in both cultured neurons and TRPV1-transfected human embryonic kidney (HEK) cells, a mechanism that involved TRPV1 ubiquitination and subsequent accumulation at the plasma membrane. Importantly, although TRPV1-deficient animals experienced similar disease severity and pain as wild-type mice in the acute phase of colitis, TRPV1 deletion prevented the development of postinflammatory visceral hypersensitivity and pain-associated behaviors. Collectively, our results suggest that chronic exposure of colon-innervating primary afferents to SP could sensitize TRPV1 and thus participate in the establishment of persistent abdominal pain following acute inflammation.
Copyright © 2015 the American Physiological Society.

Entities:  

Keywords:  inflammatory bowel disease; peripheral sensitization; substance P; transient receptor potential vanilloid 1; visceral pain

Mesh:

Substances:

Year:  2015        PMID: 26021808     DOI: 10.1152/ajpgi.00421.2014

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  33 in total

Review 1.  Sensory neuron regulation of gastrointestinal inflammation and bacterial host defence.

Authors:  N Y Lai; K Mills; I M Chiu
Journal:  J Intern Med       Date:  2017-02-02       Impact factor: 8.989

2.  TRPV1-Targeted Drugs in Development for Human Pain Conditions.

Authors:  Mircea Iftinca; Manon Defaye; Christophe Altier
Journal:  Drugs       Date:  2021-01       Impact factor: 9.546

3.  TRPV1 in experimental autoimmune prostatitis.

Authors:  Kenny Roman; Christel Hall; Anthony J Schaeffer; Praveen Thumbikat
Journal:  Prostate       Date:  2019-10-01       Impact factor: 4.104

4.  Regulation of transient receptor potential cation channel subfamily V1 protein synthesis by the phosphoinositide 3-kinase/Akt pathway in colonic hypersensitivity.

Authors:  Shanwei Shen; Hamad W Al-Thumairy; Fiza Hashmi; Li-Ya Qiao
Journal:  Exp Neurol       Date:  2017-06-03       Impact factor: 5.330

Review 5.  Supraspinal Mechanisms of Intestinal Hypersensitivity.

Authors:  Olga A Lyubashina; Ivan B Sivachenko; Sergey S Panteleev
Journal:  Cell Mol Neurobiol       Date:  2020-10-08       Impact factor: 5.046

Review 6.  The gut, its microbiome, and the brain: connections and communications.

Authors:  Michael D Gershon; Kara Gross Margolis
Journal:  J Clin Invest       Date:  2021-09-15       Impact factor: 19.456

7.  Symptoms associated with healthcare resource utilization in the setting of inflammatory bowel disease.

Authors:  Kaleb Bogale; Parth Maheshwari; Mitchell Kang; Venkata Subhash Gorrepati; Shannon Dalessio; Vonn Walter; August Stuart; Walter Koltun; Nana Bernasko; Andrew Tinsley; Emmanuelle D Williams; Kofi Clarke; Matthew D Coates
Journal:  Sci Rep       Date:  2022-06-22       Impact factor: 4.996

8.  Granulocyte-colony-stimulating factor (G-CSF) signaling in spinal microglia drives visceral sensitization following colitis.

Authors:  Lilian Basso; Tamia K Lapointe; Mircea Iftinca; Candace Marsters; Morley D Hollenberg; Deborah M Kurrasch; Christophe Altier
Journal:  Proc Natl Acad Sci U S A       Date:  2017-10-02       Impact factor: 11.205

Review 9.  A Review of the Effects of Pain and Analgesia on Immune System Function and Inflammation: Relevance for Preclinical Studies.

Authors:  George J DeMarco; Elizabeth A Nunamaker
Journal:  Comp Med       Date:  2019-12-20       Impact factor: 0.982

Review 10.  Sensory Neurons, Neuroimmunity, and Pain Modulation by Sex Hormones.

Authors:  Melissa E Lenert; Amanda Avona; Katherine M Garner; Luz R Barron; Michael D Burton
Journal:  Endocrinology       Date:  2021-08-01       Impact factor: 5.051

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.